← Back
$ALLO All transactions

Allogene Therapeutics, Inc.

A

$ Value

$0

Shares

263,033

Price

$0

Filed

Feb 4

Insider

Name

Belldegrun Arie

Title

CIK

0001296549

Roles

Director

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

263,033

Footnotes

The securities are held in the name of Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary | The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. There porting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. | The securities are held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. Vida Ventures GP III, LLC is the manager of Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person is a Senior Managing Director of Vida Ventures GP III, LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. | The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun. | 25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter. | Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period from February 2, 2026, subject to continued service through the vesting date.

Filing Info

Accession No.

0001296549-26-000002

Form Type

4

Issuer CIK

0001737287

Belldegrun Arie's History

Date Ticker Type Value
2026-02-02 ALLO A $0
2026-02-02 ALLO A $0
2025-08-26 URGN A $0
2025-06-20 KRON U $1.6M
2025-06-20 KRON U $387K
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-20 KRON D $0

Other Insiders at ALLO (90d)

Insider Bought Sold Last
Belldegrun Arie 2026-02-02
Douglas Earl Martin
SVP, General Counsel
$40K 2026-02-02
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
$42K 2026-02-02
Chang David D
President and CEO
$171K 2026-02-02
Yoshiyama Annie
SVP, Finance
$29K 2026-04-21
Roberts Zachary
EVP of R&D
$63K 2026-02-02
Beneski Benjamin Machinas
SVP, Chief Technical Officer
$20K 2026-03-31